StockData
Relay Therapeutics, Inc. logo

Relay Therapeutics, Inc. (RLAY) stock

RLAYNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 10/30
$16.47−0.80 (-4.63%)

Close on Nov 17, 2026Market cap $3.61BP/E –Yield –

Relay Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Relay Therapeutics's market cap was $4.31B on Nov 11, 2026, against $1.37B a year earlier. Over the last 5 years it ranged from $439.52M to $4.31B, with a median of $1.38B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$4.31B+195.1%
2025Dec 31, 2025$1.46B+112.4%
2024Dec 31, 2024$687.57M-49.3%
2023Dec 29, 2023$1.36B-24.9%
2022Dec 30, 2022$1.80B-36.7%
2021Dec 31, 2021$2.85B-23.6%
2020Dec 31, 2020$3.73B–

More Relay Therapeutics figures

See a number that looks wrong?